JP2013530990A - 創傷治療に係るラクトフェリンの配列、組成物、及び方法 - Google Patents

創傷治療に係るラクトフェリンの配列、組成物、及び方法 Download PDF

Info

Publication number
JP2013530990A
JP2013530990A JP2013516908A JP2013516908A JP2013530990A JP 2013530990 A JP2013530990 A JP 2013530990A JP 2013516908 A JP2013516908 A JP 2013516908A JP 2013516908 A JP2013516908 A JP 2013516908A JP 2013530990 A JP2013530990 A JP 2013530990A
Authority
JP
Japan
Prior art keywords
blf
lobe
lactoferrin
wound
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013516908A
Other languages
English (en)
Japanese (ja)
Inventor
ベンジャミン デイビッド アッシュビー
チェン ギャレット
マーク ウィルコックス
Original Assignee
ブライエン ホールデン ビジョン インスティテュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902932A external-priority patent/AU2010902932A0/en
Application filed by ブライエン ホールデン ビジョン インスティテュート filed Critical ブライエン ホールデン ビジョン インスティテュート
Publication of JP2013530990A publication Critical patent/JP2013530990A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2013516908A 2010-07-01 2011-07-01 創傷治療に係るラクトフェリンの配列、組成物、及び方法 Withdrawn JP2013530990A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010902932 2010-07-01
AU2010902932A AU2010902932A0 (en) 2010-07-01 Lactoferrin sequences, compositions and methods of wound treatment
PCT/AU2011/000826 WO2012000054A1 (en) 2010-07-01 2011-07-01 Lactoferrin sequences, compositions and methods of corneal wound treatment

Publications (1)

Publication Number Publication Date
JP2013530990A true JP2013530990A (ja) 2013-08-01

Family

ID=45401232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013516908A Withdrawn JP2013530990A (ja) 2010-07-01 2011-07-01 創傷治療に係るラクトフェリンの配列、組成物、及び方法

Country Status (10)

Country Link
US (1) US20130101575A1 (enExample)
EP (1) EP2588128A4 (enExample)
JP (1) JP2013530990A (enExample)
CN (1) CN103037894A (enExample)
AU (1) AU2011274244A1 (enExample)
CA (1) CA2803932A1 (enExample)
IN (1) IN2013CN00089A (enExample)
SG (1) SG186841A1 (enExample)
TW (1) TW201204384A (enExample)
WO (1) WO2012000054A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110606A1 (it) * 2011-11-16 2013-05-17 Ist Superiore Sanita Peptidi della lattoferrina per lo uso come inibitori ad ampio spettro dellainfezione da virus della influenza.
WO2019089878A1 (en) * 2017-11-02 2019-05-09 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation
CN117024518B (zh) * 2023-08-29 2025-07-25 百葵锐(深圳)生物科技有限公司 一种生物活性肽及其应用
CN118146346B (zh) * 2024-05-09 2024-08-06 杭州岛屿星晴生物技术有限公司 一种仿生胎脂蛋白肽的制备方法及其产品和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0579830T3 (da) * 1990-11-13 1997-08-18 Santen Pharmaceutical Co Ltd Terapeutisk middel til hornhindebeskadigelse
DE60335997D1 (de) * 2002-09-16 2011-03-24 Agennix Inc Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
WO2006054908A1 (en) * 2004-11-19 2006-05-26 Fonterra Corporate Research And Development Limited Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
AU2006300009A1 (en) * 2005-10-14 2007-04-19 Auckland Uniservices Limited Use of lactoferrin fragments and hydrolysates
NZ552316A (en) * 2006-12-22 2009-10-30 Fonterra Co Operative Group Dairy product and process

Also Published As

Publication number Publication date
AU2011274244A1 (en) 2013-01-10
EP2588128A4 (en) 2014-03-19
WO2012000054A1 (en) 2012-01-05
EP2588128A1 (en) 2013-05-08
TW201204384A (en) 2012-02-01
CN103037894A (zh) 2013-04-10
IN2013CN00089A (enExample) 2015-07-03
US20130101575A1 (en) 2013-04-25
CA2803932A1 (en) 2012-01-05
SG186841A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
US20220332773A1 (en) Silk-derived protein for treating inflammation
JP5438968B2 (ja) 両親媒性ポリマー−ｐｄｇｆ複合体
US20120315256A1 (en) Use of transforming growth factor - beta 1 (tgf-b1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
EP2508196A1 (en) Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
TW201709916A (zh) 用於防止上皮細胞增生及上皮－間質轉移之組合物及方法
US11723954B2 (en) Therapeutic and cosmetic uses and applications of calreticulin
JP2009501201A (ja) 上皮再生の促進
JP2013530990A (ja) 創傷治療に係るラクトフェリンの配列、組成物、及び方法
US20240041987A1 (en) Novel bioactive peptide combinations and uses thereof
AU2015384099B2 (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
HK1182337A (en) Lactoferrin sequences, compositions and methods of corneal wound treatment
WO2022204331A1 (en) Compositions comprising branched kgf-2 derived peptides and methods for use in ocular treatment
WO2024091513A1 (en) Biomimetic extracellular matrix nanofibers electrospun with calreticulin
HK1241379B (zh) 短合成肽及其治疗和/或预防乾眼症的用途

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20140902